CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Cytosorbents Corp ( (CTSO) ) has released its Q3 earnings. Here is a breakdown of the information Cytosorbents Corp presented to its investors.

PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

At this time, I would like to welcome everyone to the CytoSorbents' Corporation Third Quarter 2024 Earnings Call. [Operator Instructions]. I would now like to turn the call over to Investor ...

CytoSorbents Corporation (NASDAQ: CTSO) and Converge Biotech, a prominent healthcare company with a strong critical care and infectious disease focus in India, are pleased to announce a new strategic ...

About CytoSorbents Corporation (NASDAQ: CTSO)CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood ...

About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.